Literature DB >> 23105739

Study of genetic, metabolic and inflammatory risk factors in patients of acute ischemic stroke.

Rajinder K Dhamija1, Sarika Arora, P Gaba, M Jais, A Kaintura, M Kumar, J Bhattacharjee.   

Abstract

Stroke is the third leading cause of death and foremost cause of disability. Based on studies in CAD patients, a focus has been shifted on genetic and inflammatory markers as risk factors for stroke besides deranged lipid profile. The present study was aimed to ascertain the role of Lipoprotein (a), C-Reactive protein (CRP) levels and lipids in patients of ischemic stroke. The study was done in 82 subjects including 40 Computerized Tomography (CT) proven patients of ischemic stroke and 42 age and sex matched controls. Complete biochemical parameters including lipid profile were carried out on autoanalyzer using standard kits and reagents. Lipoprotein (a) [Lp(a)] was determined by immunoturbidimetric assay. Atherogenic indices (Total cholesterol/ HDL, LDL/HDL and Lipid Tetrad Index) were calculated using these lipid parameters. The CRP levels were measured semi-quantitatively by latex agglutination test method. Out of 40 stroke patients, 38 had abnormalities in lipid profile (As per ATP III guidelines). A significant difference was seen in serum cholesterol, LDL cholesterol and atherogenic indices between the patients and controls. The difference in CRP levels in cases and control subjects was highly significant (4.78±0.72 mg/dl vs 0.76 ±0.70, p<0.001). 96.5% of patients with raised CRP had abnormal lipid levels also. CRP levels in stroke patients showed significant correlation with total cholesterol and LDL (p<0.001), Lp (a) (p=0.002) and atherogenic indices (p<0.05). Raised CRP levels in stroke patients were significantly associated with large territory infarcts, severe disability and poor functional outcome (p<0.05).Genetic [Lp(a)], metabolic (deranged Lipid profile) and inflammatory factors (CRP) together are instrumental in causing cerebrovascular arteriosclerosis leading to ischaemic stroke and can be used as important markers to identify patients at risk of severe stroke and to institute aggressive preventive strategies.

Entities:  

Keywords:  Atherogenic Indices; C - reactive protein; Ischemic stroke; Lipid profile; Lipoprotein (a)

Year:  2008        PMID: 23105739      PMCID: PMC3453092          DOI: 10.1007/s12291-008-0031-5

Source DB:  PubMed          Journal:  Indian J Clin Biochem        ISSN: 0970-1915


  36 in total

1.  C-reactive protein and outcome after ischemic stroke.

Authors:  K W Muir; C J Weir; W Alwan; I B Squire; K R Lees
Journal:  Stroke       Date:  1999-05       Impact factor: 7.914

2.  Homocysteine and lipoprotein(a) interact to increase CAD risk in young men and women.

Authors:  J M Foody; J A Milberg; K Robinson; G L Pearce; D W Jacobsen; D L Sprecher
Journal:  Arterioscler Thromb Vasc Biol       Date:  2000-02       Impact factor: 8.311

Review 3.  C-reactive protein, stroke, and statins.

Authors:  Allan D Angerio; Matthew F Bialko; Bradley M White
Journal:  Crit Care Nurs Q       Date:  2007 Apr-Jun

4.  Lipoprotein(a) as an independent risk factor for coronary artery disease in patients below 40 years of age.

Authors:  J K Gambhir; H Kaur; D S Gambhir; K M Prabhu
Journal:  Indian Heart J       Date:  2000 Jul-Aug

5.  C-reactive protein as a predictor of incident ischemic stroke among patients with preexisting cardiovascular disease.

Authors:  David Tanne; Michal Benderly; Uri Goldbourt; Moti Haim; Alexander Tenenbaum; Enrique Z Fisman; Zipora Matas; Yehuda Adler; Reuven Zimmlichman; Solomon Behar
Journal:  Stroke       Date:  2006-06-01       Impact factor: 7.914

6.  Lipid levels and the risk of ischemic stroke in women.

Authors:  T Kurth; B M Everett; J E Buring; C S Kase; P M Ridker; J M Gaziano
Journal:  Neurology       Date:  2007-02-20       Impact factor: 9.910

7.  Xuezhikang decreases serum lipoprotein(a) and C-reactive protein concentrations in patients with coronary heart disease.

Authors:  Ling Liu; Shui-Ping Zhao; Yan-Chun Cheng; Yu-Ling Li
Journal:  Clin Chem       Date:  2003-08       Impact factor: 8.327

8.  C-reactive protein adds to the predictive value of total and HDL cholesterol in determining risk of first myocardial infarction.

Authors:  P M Ridker; R J Glynn; C H Hennekens
Journal:  Circulation       Date:  1998-05-26       Impact factor: 29.690

9.  Angiotensin-converting enzyme inhibitor use is associated with reduced plasma concentration of C-reactive protein in patients with first-ever ischemic stroke.

Authors:  Mario Di Napoli; Francesca Papa
Journal:  Stroke       Date:  2003-11-06       Impact factor: 7.914

10.  The role of lipid profile as a risk factor indicator for ischemic stroke at Cipto Mangunkusumo Hospital, Jakarta.

Authors:  Suzanna Immanuel; Astuti Giantini; Rahajuningsih S Dharma
Journal:  Acta Med Indones       Date:  2006 Jan-Mar
View more
  1 in total

1.  Acute Ischemic Stroke is Associated with Increased Serum Levels of Pro-inflammatory Cytokines.

Authors:  Bhagirath Ramawat; Alvee Saluja; Jayashree Bhatacharjee; Anshuman Srivastava; Rajinder K Dhamija
Journal:  Indian J Clin Biochem       Date:  2020-05-27
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.